Bridion (sugammadex)
/ Merck (MSD)
- LARVOL DELTA
Home
Next
Prev
1 to 25
Of
2169
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
September 25, 2026
The SNaPP Study: Sugammadex, neostigmine and postoperative pulmonary complications (SNaPP): a randomised controlled trial
(ANZCTR)
- P4 | N=3500 | Completed | Sponsor: University of Melbourne | Active, not recruiting ➔ Completed
Trial completion • Acute Respiratory Distress Syndrome • Anesthesia • Infectious Disease • Pneumonia • Pulmonary Disease • Respiratory Diseases
September 25, 2026
Sugammadex vs. neostigmine: the train-of-four counts too.
(PubMed, Anaesthesia)
- No abstract available
Journal
September 23, 2026
REMI-MEP: REMIfentanil (2 vs. 4 mcg/kg) Facilitated Intubation Without Neuromuscular Blockade Versus Succinylcholine and Rocuronium With Sugammadex for Endotracheal Intubation in Spine Surgery Requiring Motor Evoked Potential Monitoring
(clinicaltrials.gov)
- P4 | N=316 | Not yet recruiting | Sponsor: Mayo Clinic
Intubation • New P4 trial • Orthopedics
September 23, 2026
Sudden, Severe, Refractory Hypotension Following Sugammadex Administration During Low-Risk Orthopedic Surgery in a Healthy Young Adult: A Case Report.
(PubMed, Case Rep Anesthesiol)
- "Although causality cannot be definitively established, the temporal relationship raises concern for sugammadex-associated hypotension without bradycardia, possibly related to an atypical hypersensitivity reaction. This case highlights that severe hypotension may occur even in low-risk patients in the absence of bradycardia or other classic features of anaphylaxis, requiring prompt recognition and early potent vasopressor support."
Journal • Cardiovascular • Hypotension • Immunology • Orthopedics
September 18, 2026
Clinical application of sugammadex in renal impairment: pharmacokinetics and pharmacodynamics.
(PubMed, Front Pharmacol)
- "Sugammadex, a modified γ-cyclodextrin, rapidly and predictably reverses aminosteroid neuromuscular blockade by directly encapsulating rocuronium and vecuronium, thereby avoiding the cholinergic adverse effects associated with acetylcholinesterase inhibitors. Overall, sugammadex may serve as an effective and generally well-tolerated reversal agent in carefully selected patients with severe renal impairment. Additional prospective studies are required to establish its long-term safety and guide clinical recommendations."
Journal • PK/PD data • Review • Chronic Kidney Disease • Nephrology • Renal Disease
September 18, 2026
Prospective, randomized comparison of electromyographic neuromuscular responses from the adductor pollicis and abductor digiti minimi muscles during rocuronium-induced neuromuscular block.
(PubMed, Anesthesiology)
- "The present study underscores the equivalency between ADM and AP muscles for routine neuromuscular monitoring during surgery. When monitoring the non-dominant arm, the ADM and AP muscles have similar recoveries. In the dominant arm, the ADM muscle recovery is significantly faster than that of the AP muscle."
Journal • Anesthesia
September 16, 2026
Application of sugammadex sodium in the recovery period of general anesthesia in patients with uvulopalatopharyngoplasty
(ChiCTR)
- P=N/A | N=80 | Completed | Sponsor: The Second Norman Bethune Hospital of Jilin University; The Second Norman Bethune Hospital of Jilin University | Not yet recruiting ➔ Completed
Trial completion • Anesthesia • Obstructive Sleep Apnea • Respiratory Diseases • Sleep Disorder
September 16, 2026
Effect of Sugammadex Sodium on Neuromuscular Blockade Reversal and Postoperative Recovery in Elderly Patients Undergoing Thoracoscopic Lung Surgery: A Randomized Controlled Trial
(ChiCTR)
- P=N/A | N=120 | Not yet recruiting | Sponsor: The First Affiliated Hospital of Guangzhou Medical University; The First Affiliated Hospital of Guangzhou Medical University
New trial
September 16, 2026
Turning over new stones and discovering new questions in the contributions of anaesthetic drugs to perioperative cardiac arrest.
(PubMed, Br J Anaesth)
- "Using data from VigiBase, Perez and Fettiplace established a Risk of Reporting (RoR) metric for each common anaesthetic agent, comparing the occurrence of cardiac arrest associated with a given agent relative to its reported use in the database with propofol as the reference agent. This 'RoR' metric can inform future research into the association between specific anaesthesia medications and the risk for perioperative cardiac arrest."
Journal • Review • Anesthesia • Cardiovascular
September 16, 2026
Impact of Sugammadex on Clinical and Patient-Centered Outcomes: Beyond Neuromuscular Recovery.
(PubMed, J Clin Med)
- "Sugammadex provides rapid and predictable reversal of rocuronium- and vecuronium-induced blockade and reduces residual neuromuscular blockade more effectively than conventional anticholinesterase-based reversal. Sugammadex may be associated with favorable selected postoperative outcomes, but it should not be regarded as an independent determinant of recovery. Its clinical effects must be interpreted as part of optimized neuromuscular management incorporating quantitative monitoring, blockade-depth-appropriate dosing, confirmation of recovery, and comprehensive perioperative care."
Journal • Review • Anesthesia • Cardiovascular • CNS Disorders • Immunology • Pain • Renal Disease
September 12, 2026
Era of Sugammadex: Reply.
(PubMed, Anesthesiology)
- No abstract available
Journal
September 12, 2026
Era of Sugammadex: Comment.
(PubMed, Anesthesiology)
- No abstract available
Journal
September 12, 2026
Era of Sugammadex: Comment.
(PubMed, Anesthesiology)
- No abstract available
Journal
September 12, 2026
Era of Sugammadex: Comment.
(PubMed, Anesthesiology)
- No abstract available
Journal
September 12, 2026
Sugammadex for preventIoN oF pOst-operative pulmoNary complIcAtions (SINFONIA): protocol for an embedded mixed-methods process evaluation.
(PubMed, BJA Open)
- "ISRCTN.com ISRCTN15109717. Registered on 21 December 2022."
Clinical • Journal • Anesthesia • Critical care
September 12, 2026
Era of Sugammadex: Comment.
(PubMed, Anesthesiology)
- No abstract available
Journal
September 11, 2026
Bradycardia at Emergence after Percutaneous Pulmonary Valve Implantation in an Adult with Repaired Transposition of the Great Arteries and Pulmonary Atresia.
(PubMed, J Cardiothorac Vasc Anesth)
- No abstract available
Journal • Cardiovascular
September 04, 2026
Serial Fetal Heart Rate Monitoring During Electroconvulsive Therapy in Late Pregnancy: A Case Report of Transition From Succinylcholine to Rocuronium Reversed With Neostigmine.
(PubMed, Neuropsychopharmacol Rep)
- "Postpartum ECT was resumed for five additional sessions using rocuronium reversed with sugammadex, and the patient achieved clinical remission. This case suggests the feasibility of rocuronium with neostigmine reversal as an alternative to succinylcholine for ECT during late pregnancy when succinylcholine is unavailable, provided that multidisciplinary management and fetal monitoring are available."
Journal • CNS Disorders • Depression • Major Depressive Disorder • Mental Retardation • Mood Disorders • Psychiatry • Respiratory Diseases • Suicidal Ideation
September 04, 2026
Safety and Efficacy of Using Sugammadex in Pediatric Patients: A Narrative Review.
(PubMed, J Pain Res)
- "Overall, sugammadex provides a promising alternative to current therapies with vast implications for clinical anesthesia practice in pediatrics. Further studies are needed to investigate optimal practices in dosing, safety, and cost-effectiveness in pediatric subgroups."
Journal • Review • Anesthesia • Cardiovascular • Hypotension • Pediatrics
September 02, 2026
Precision TOF-Guided Sugammadex Versus Spontaneous Recovery for Early Extubation in Minimally Invasive Pediatric Cardiac Surgery
(clinicaltrials.gov)
- P=N/A | N=80 | Recruiting | Sponsor: Dr. Nguyen Thi Thu Hang
New trial • Cardiovascular • Pediatrics
September 02, 2026
Urinary Difficulty After General Anesthesia for Otolaryngology Head and Neck Surgery.
(PubMed, Ear Nose Throat J)
- "No patients with rocuronium plus sugammadex had POUD.ConclusionsPOUD is common following otolaryngology head and neck surgery, particularly in older male patients and with prolonged operation time. It is essential to develop targeted interventional strategies to prevent and manage POUD in these high-risk groups."
Journal • Anesthesia • Otorhinolaryngology
August 28, 2026
Total Rocuronium Requirement During Intermittent Bolus Versus Continuous Infusion for Deep Neuromuscular Block in Elective Abdominal Cancer Surgery: A Randomized Equivalence Trial.
(PubMed, J Clin Med)
- " This prospective, single-center, randomized equivalence trial enrolled 72 adults undergoing elective abdominal cancer surgery under sevoflurane-remifentanil anesthesia...Deep NMB duration (127 ± 43 vs. 132 ± 65 min; p = 0.687) and recovery after sugammadex did not differ significantly...Recovery outcomes did not differ significantly; however, the infusion protocol required rescue boluses in some patients. PTC-guided individualization is therefore needed."
Journal • Anesthesia • Oncology
August 26, 2026
Comparison of kinemyography and electromyography during onset of and recovery from non-depolarising neuromuscular blockade: prospective observational study.
(PubMed, Anaesthesiol Intensive Ther)
- "KMG and EMG are not interchangeable for perioperative neuromuscular monitoring; the observed disagreement suggests that KMG may overestimate neuromuscular block, whereas EMG-based monitoring may provide a safer approach. The EMG-derived parameter T1% appears promising but requires further validation before routine clinical use."
Clinical • Journal • Observational data • Anesthesia
August 26, 2026
Neuromuscular Blockade Comparison for GI-2 Recovery After Bowel Resection
(clinicaltrials.gov)
- P4 | N=132 | Completed | Sponsor: University of California, Irvine | Recruiting ➔ Completed | Trial primary completion date: Jul 2026 ➔ Mar 2026
Trial completion • Trial primary completion date • Gastrointestinal Disorder
August 25, 2026
Does Sugammadex Decrease Length of Stay in Bariatric Surgery? Experience from an MBSAQIP Comprehensive Bariatric Center.
(PubMed, Obes Surg)
- "Sugammadex use was associated with significantly lower odds of prolonged hospital stay following elective bariatric surgery. Procedure complexity and higher BMI were also independent predictors. Further prospective studies are warranted to confirm these findings."
Journal • Anesthesia
1 to 25
Of
2169
Go to page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87